Related Experiment Videos
Myelography wiht perfluoroctylbromide. Comparison with Pantopaque
Abstract:
The efficacy and toxicity of perfluoroctylbromide in myelography were studied in dogs. Perfluoroctylbromide moves freely in intrathecal space and provides satisfactory radiopacity for diagnosis of subarachnoid structures. The outstanding feature of this substance is its low toxicity. The dog tolerates 0.5-1.0 ml/kg intrathecally without toxic manifestation. Histological studies and CSF analyses show that it is much less irriating than Pantopaque. Because of the long retention of the perfluorocarbon removal may be necessary. Perfluoroctylbromide shows promise as a diagnostic contrast medium, particularly in cases where the currently available contrast media are not suitable.
Insights
Perfluoroctylbromide is a promising, low-toxicity contrast agent for myelography, offering good radiopacity for subarachnoid imaging in dogs. Further study may be needed regarding its long retention in the intrathecal space.
Area of Science:
- Radiology
- Toxicology
- Veterinary Medicine
Background:
- Myelography requires effective and safe contrast media for diagnosing subarachnoid space abnormalities.
- Current contrast agents like Pantopaque may cause irritation and have limitations.
Purpose of the Study:
- To evaluate the efficacy and toxicity of perfluoroctylbromide as a contrast medium for intrathecal use in dogs.
Main Methods:
- Dogs were administered varying doses of perfluoroctylbromide intrathecally.
- Efficacy was assessed by radiopacity and diagnostic quality.
- Toxicity was evaluated through clinical signs, histological studies, and cerebrospinal fluid (CSF) analysis.
Main Results:
- Perfluoroctylbromide demonstrated free movement within the intrathecal space and provided satisfactory radiopacity.
- Dogs tolerated doses of 0.5-1.0 ml/kg without observable toxic manifestations.
- Histological findings and CSF analyses indicated significantly less irritation compared to Pantopaque.
Conclusions:
- Perfluoroctylbromide exhibits a favorable safety profile and diagnostic utility for myelography in canine models.
- Its low toxicity and good radiopacity make it a promising alternative contrast agent.
- Consideration for perfluorocarbon removal may be necessary due to its long retention time.